Table of Contents
From the Editor
- A new reason to reconsider that antibiotic prescription: The microbiome
Prescribing an antibiotic is a far more complicated and long-lasting affair than most of us thought.
The Clinical Picture
1-Minute Consult
- What can I do when first-line measures are not enough for vasovagal syncope?
Second-line measures include midodrine, fludrocortisone, beta-blockers, and SSRIs, but evidence is limited.
- Are anti-TNF drugs safe for pregnant women with inflammatory bowel disease?
Active IBD poses a greater risk than continuing drug therapy.
- Do all hospital inpatients need cardiac telemetry?
Routine cardiac telemetry raises costs and does little.
Medical Grand Rounds
- Our missing microbes: Short-term antibiotic courses have long-term consequences
Is the rise in chronic diseases due to loss of microbial diversity?
Review
- Beta-cell therapies for type 1 diabetes: Transplants and bionics
Chief among the challenges: millions of people have diabetes.
- Cannabis for peripheral neuropathy: The good, the bad, and the unknown
Even where it is legal, doctors should recommend it only after careful consideration.
- Geriatrics update 2018: Challenges in mental health, mobility, and postdischarge care
A review of study results from the last 2 years.
Opinion
- Telemedicine: Past, present, and future
Low reimbursement, licensing, practice issues limit its use.
- Cannabis for chronic pain: Not a simple solution
Real concerns include amotivation, worsening psychiatric states, chronic disability, and chemical dependence.
Departments
- Prostate cancer screening, November 2018
A reader comments on the use of prostate-specific antigen (November 2018).
- Men’s health 2018 (November 2018)
An error occurred in Chaitoff A, Killeen TC, Nielsen C. Men’s health 2018: BPH, prostate cancer, erectile dysfunction, supplements. Cleve Clin J Med 2018; 85(11):871–880. doi:10.3949/ccjm.85a.18011.